Dirk Hasenclever

A Prognostic Score for Advanced Hodgkin's Disease

Dirk Hasenclever, Volker Diehl, Jamés O. Armitage et al. · New England Journal of Medicine · 1998 · 1.7K citations · Full text

Medicine, Oncology, Radiation Oncology +14

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

Norbert Schmitz, Beate Pfistner, M. Sextro et al. · The Lancet · 2002 · 1.1K citations

Medicine, Clinical Sciences, Oncology +13

A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling

Michael Hummel, Stefan Bentink, Hilmar Berger et al. · New England Journal of Medicine · 2006 · 1K citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease

Volker Diehl, Jeremy Franklin, Michael Pfreundschuh et al. · New England Journal of Medicine · 2003 · 833 citations · Full text

Medicine, Oncology, Pharmacology +11

A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery

Patrick Meybohm, Berthold Bein, Oana Brosteanu et al. · New England Journal of Medicine · 2015 · 633 citations · Full text

Medicine, Anesthesiology, Surgery +10